Integra LifeSciences Holdings Gross Profit 2010-2024 | IART

Integra LifeSciences Holdings gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Integra LifeSciences Holdings Annual Gross Profit
(Millions of US $)
2023 $885
2022 $970
2021 $945
2020 $851
2019 $953
2018 $901
2017 $753
2016 $643
2015 $556
2014 $494
2013 $417
2012 $516
2011 $481
2010 $464
2009 $438
Integra LifeSciences Holdings Quarterly Gross Profit
(Millions of US $)
2024-09-30 $200
2024-06-30 $226
2024-03-31 $207
2023-12-31 $226
2023-09-30 $218
2023-06-30 $207
2023-03-31 $233
2022-12-31 $250
2022-09-30 $237
2022-06-30 $249
2022-03-31 $234
2021-12-31 $249
2021-09-30 $242
2021-06-30 $239
2021-03-31 $214
2020-12-31 $242
2020-09-30 $235
2020-06-30 $153
2020-03-31 $221
2019-12-31 $246
2019-09-30 $236
2019-06-30 $240
2019-03-31 $231
2018-12-31 $237
2018-09-30 $223
2018-06-30 $229
2018-03-31 $213
2017-12-31 $220
2017-09-30 $177
2017-06-30 $183
2017-03-31 $172
2016-12-31 $170
2016-09-30 $161
2016-06-30 $160
2016-03-31 $152
2015-12-31 $151
2015-09-30 $140
2015-06-30 $137
2015-03-31 $127
2014-12-31 $93
2014-09-30 $124
2014-06-30 $144
2014-03-31 $133
2013-12-31 $45
2013-09-30 $131
2013-06-30 $124
2013-03-31 $117
2012-12-31 $133
2012-09-30 $131
2012-06-30 $132
2012-03-31 $122
2011-12-31 $121
2011-09-30 $124
2011-06-30 $120
2011-03-31 $116
2010-12-31 $123
2010-09-30 $117
2010-06-30 $114
2010-03-31 $109
2009-12-31 $120
2009-09-30 $109
2009-06-30 $106
2009-03-31 $103
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.016B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.348B 26.52
Intuitive Surgical (ISRG) United States $203.988B 93.58
Alcon (ALC) Switzerland $45.073B 30.16
Edwards Lifesciences (EW) United States $41.952B 26.64
IQVIA Holdings (IQV) United States $35.950B 19.81
IDEXX Laboratories (IDXX) United States $34.289B 40.38
DexCom (DXCM) United States $33.759B 50.84
Waters (WAT) United States $23.998B 35.49
STERIS (STE) Ireland $21.743B 25.03
SONOVA HOLDING (SONVY) Switzerland $20.798B 0.00
Hologic (HOLX) United States $16.119B 17.50
Fresenius Medical Care AG KGaA (FMS) Germany $14.577B 14.96
Globus Medical (GMED) United States $12.635B 32.00
Sysmex ADR (SSMXY) Japan $12.243B 38.39
Penumbra (PEN) United States $10.352B 101.40
Masimo (MASI) United States $9.509B 46.01
Glaukos (GKOS) United States $8.767B 0.00
Teleflex (TFX) United States $8.387B 13.38
Integer Holdings (ITGR) United States $4.804B 27.23
Inari Medical (NARI) United States $4.666B 0.00
PROCEPT BioRobotics (PRCT) United States $3.807B 0.00
Veracyte (VCYT) United States $3.444B 103.35
LivaNova (LIVN) United Kingdom $2.755B 15.90
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Tandem Diabetes Care (TNDM) United States $2.388B 0.00
Elekta AB (EKTAY) Sweden $2.309B 20.76
TransMedics (TMDX) United States $2.199B 69.71
Alphatec Holdings (ATEC) United States $1.710B 0.00
Artivion (AORT) United States $1.309B 86.72
RxSight (RXST) United States $1.273B 0.00
Pulse Biosciences (PLSE) United States $1.214B 0.00
Paragon 28 (FNA) United States $1.088B 0.00
OPKO Health (OPK) United States $1.024B 0.00
AxoGen (AXGN) United States $0.806B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.795B 13.51
IRadimed (IRMD) United States $0.759B 40.99
Mesa Laboratories (MLAB) United States $0.743B 17.51
SiBone (SIBN) United States $0.722B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.715B 0.00
Treace Medical Concepts (TMCI) United States $0.649B 0.00
OrthoPediatrics (KIDS) United States $0.602B 0.00
AngioDynamics (ANGO) United States $0.504B 0.00
Delcath Systems (DCTH) United States $0.500B 0.00
ClearPoint Neuro (CLPT) United States $0.491B 0.00
Semler Scientific (SMLR) United States $0.483B 25.41
NeuroPace (NPCE) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.429B 23.23
Pacific Biosciences Of California (PACB) United States $0.427B 0.00
CVRx (CVRX) United States $0.409B 0.00
Inogen (INGN) United States $0.298B 0.00
Alpha Tau Medical (DRTS) Israel $0.255B 0.00
Accuray (ARAY) United States $0.223B 0.00
Anteris Technologies Global (AVR) Australia $0.214B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
Nevro (NVRO) United States $0.190B 0.00
Sight Sciences (SGHT) United States $0.155B 0.00
LENSAR (LNSR) United States $0.129B 0.00
Sensus Healthcare (SRTS) United States $0.110B 11.75
Atossa Genetics (ATOS) United States $0.107B 0.00
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Neuronetics (STIM) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.096B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
908 Devices (MASS) United States $0.082B 0.00
Vicarious Surgical (RBOT) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
Rapid Micro Biosystems (RPID) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
EnVVeno Medical (NVNO) United States $0.055B 0.00
Lucid Diagnostics (LUCD) United States $0.053B 0.00
Positron (POSC) United States $0.051B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.036B 0.00
WORK Medical Technology Group (WOK) China $0.036B 0.00
Spectral AI (MDAI) United States $0.034B 0.00
Accelerate Diagnostics (AXDX) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Adagio Medical Holdings (ADGM) United States $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00